Kebapci M, Entok E, Kebapci N, Adapinar B
Department of Radiology, Osmangazi University Medical Faculty, Eskisehir, Turkey.
J Endocrinol Invest. 2004 Jan;27(1):24-30. doi: 10.1007/BF03350906.
The aim of this study was to evaluate the sensitivity and usefulness of high resolution ultrasonography (US) and dual phase technetium-99m sestamibi (Tc-MIBI) scintigraphy in the preoperative localization of parathyroid lesions in patients with or without thyroid disease and to define the impact of the presence of thyroid disease on these methods. Preoperative US and scintigraphy were performed on 52 patients with primary hyperparathyroidism. Age, gender, preoperative parathyroid hormone level, serum calcium level, serum phosphate level, diameter, location, associated with thyroid abnormality, and results of parathyroid exploration were determined in all patients. The results of US and Tc-MIBI imaging were analyzed and compared with surgical and histopathologic findings. At surgery, 56 parathyroid lesions were found in 52 patients (9 men, 43 women), the parathyroid lesion was solitary (47 adenomas, two hyperplasias), in 2 patients double adenomas were present, in 1 patient three glands was affected by hyperplasia. Twenty-seven patients had concomitant thyroid disease. The overall sensitivity of US and Tc-MIBI scintigraphy was 84% and 73%, respectively. In patients without thyroid disease, the sensitivity of these techniques was 90% and 75%, respectively. In patients with thyroid disease, the sensitivity was 78% and 70%, respectively. In patients with thyroid disease, the combined sensitivity of these techniques was 89%. These results allow the conclusion that, in experienced hands, US is a highly sensitive technique. Especially in patients with no thyroid pathology and typical located gland, US alone should be used as a first step for preoperative localization of parathyroid lesions. When negative, Tc-MIBI scintigraphy is suggested. In patients with concomitant thyroid disease, the combination of US and Tc-MIBI scintigraphy represents a reliable localization technique.
本研究的目的是评估高分辨率超声(US)和双相锝-99m甲氧基异丁基异腈(Tc-MIBI)闪烁扫描术在有或无甲状腺疾病患者甲状旁腺病变术前定位中的敏感性和实用性,并确定甲状腺疾病的存在对这些方法的影响。对52例原发性甲状旁腺功能亢进患者进行了术前超声和闪烁扫描术。测定了所有患者的年龄、性别、术前甲状旁腺激素水平、血清钙水平、血清磷水平、直径、位置、是否伴有甲状腺异常以及甲状旁腺探查结果。分析了超声和Tc-MIBI成像的结果,并与手术和组织病理学结果进行了比较。手术中,52例患者(9例男性,43例女性)共发现56个甲状旁腺病变,甲状旁腺病变为单发(47个腺瘤,2个增生),2例患者存在双腺瘤,1例患者三个腺体受增生影响。27例患者伴有甲状腺疾病。超声和Tc-MIBI闪烁扫描术的总体敏感性分别为84%和73%。在无甲状腺疾病的患者中,这些技术的敏感性分别为90%和75%。在有甲状腺疾病的患者中,敏感性分别为78%和70%。在有甲状腺疾病的患者中,这些技术的联合敏感性为89%。这些结果可以得出结论,在经验丰富的医生手中,超声是一种高度敏感的技术。特别是在无甲状腺病变且腺体位置典型的患者中,应单独将超声作为甲状旁腺病变术前定位的第一步。当结果为阴性时,建议进行Tc-MIBI闪烁扫描术。在伴有甲状腺疾病的患者中,超声和Tc-MIBI闪烁扫描术的联合是一种可靠的定位技术。